16211-1-AP
antibody from Proteintech Group
Targeting: N6AMT1
C21orf127, HEMK2, KMT9, MTQ2, N6AMT, PRED28, PrmC
Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 16211-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#16211-1-AP, RRID:AB_2147186
- Product name
- N6AMT1 antibody
- Antibody type
- Polyclonal
- Description
- N6AMT1 antibody (Cat. #16211-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references β-elemene promotes ferroptosis to improve the sensitivity of imatinib in gastrointestinal stromal tumours by targeting N6AMT1.
The methyltransferase N6amt1 regulates hippocampal neurogenesis through 6 mA modification of Txnrd3 DNA.
Extracellular matrix stiffness reduces DNA 6 ma level to facilitate colorectal cancer progression via disrupting P53 binding to CDKN1A promoter.
Cross-Reactivity of N6AMT1 Antibodies with Aurora Kinase A: An Example of Antibody-Specific Non-Specificity.
BUD23-TRMT112 interacts with the L protein of Borna disease virus and mediates the chromosomal tethering of viral ribonucleoproteins.
Association of N(6)-methyladenine DNA with plaque progression in atherosclerosis via myocardial infarction-associated transcripts.
Lan J, Zhang W, Zeng K, Li C, He J, Li X, Yang R, Chi J, Hong Z, Wang W, Zhou C, Xiao B, Fan W, Lin J, Ou Q, Fang Y, Pan Z, Peng J, Li W, Wu X
Clinical and translational medicine 2025 Sep;15(9):e70438
Clinical and translational medicine 2025 Sep;15(9):e70438
The methyltransferase N6amt1 regulates hippocampal neurogenesis through 6 mA modification of Txnrd3 DNA.
Wu Y, Ma W, Li Q, Li Y, Xie L, Kong X, Chen S, Wang Q, Xuan A
Cellular and molecular life sciences : CMLS 2025 Dec 11;83(1):24
Cellular and molecular life sciences : CMLS 2025 Dec 11;83(1):24
Extracellular matrix stiffness reduces DNA 6 ma level to facilitate colorectal cancer progression via disrupting P53 binding to CDKN1A promoter.
Xie SA, Li X, Yin MY, Du F, Zhang ST, Zhu ST
Experimental hematology & oncology 2025 Aug 27;14(1):111
Experimental hematology & oncology 2025 Aug 27;14(1):111
Cross-Reactivity of N6AMT1 Antibodies with Aurora Kinase A: An Example of Antibody-Specific Non-Specificity.
Brūmele B, Serova E, Lupp A, Suija M, Mutso M, Kurg R
Antibodies (Basel, Switzerland) 2024 Apr 22;13(2)
Antibodies (Basel, Switzerland) 2024 Apr 22;13(2)
BUD23-TRMT112 interacts with the L protein of Borna disease virus and mediates the chromosomal tethering of viral ribonucleoproteins.
Garcia BCB, Horie M, Kojima S, Makino A, Tomonaga K
Microbiology and immunology 2021 Nov;65(11):492-504
Microbiology and immunology 2021 Nov;65(11):492-504
Association of N(6)-methyladenine DNA with plaque progression in atherosclerosis via myocardial infarction-associated transcripts.
Wu L, Pei Y, Zhu Y, Jiang M, Wang C, Cui W, Zhang D
Cell death & disease 2019 Dec 4;10(12):909
Cell death & disease 2019 Dec 4;10(12):909
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image

- Experimental details
- The N6AMT1 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human N6AMT1. This antibody recognizes human,mouse,rat antigen. The N6AMT1 antibody has been validated for the following applications: ELISA, WB analysis.